semaglutide cause low blood pressure and the reduction of murine Blood Pressure Changes on 10

Explore the top headlines, including results from a first-of-its-kind clinical trial testing the GLP-1 drug semaglutides effect on Alzheimers disease, a novel tau-targeting therapy, and new blood tests (biomarkers) that could help detect Alzheimers earlier

Drawing on the same body of evidence, the two decisions moved in opposite directions, affecting different populations

By approaching the discussion with your healthcare provider equipped with knowledge, questions, and an open mind, you can take an active role in determining the most suitable GLP-1 treatment plan for your individual needs

Tirzepatide Reduced the Risk of Developing Type 2 Diabetes by 94% in Adults with Pre-diabetes and Obesity or Overweight